Astrana Health (ASTH) late Thursday reported a Q4 net loss of $0.15 per diluted share, compared with earnings of $0.26 a year earlier.
Analysts polled by FactSet expected earnings of $0.10.
Revenue for the quarter ended Dec. 31 was $665.2 million up from $353 million a year earlier.
Analysts surveyed by FactSet expected $617.2 million.
The company expects 2025 revenue in the range of $2.5 billion to $2.7 billion. Analysts expected $2.58 billion.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。